February 2026
The global extracorporeal membrane oxygenation (ECMO) outsourcing service market size was estimated at USD 1.48 billion in 2025 and is predicted to increase from USD 1.62 billion in 2026 to approximately USD 3.58 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035.

The growing cardiac and respiratory diseases are increasing the demand for ECMO outsourcing services, where the increasing integration of AI and new ECMO platform launches are also enhancing the market growth.
The extracorporeal membrane oxygenation (ECMO) outsourcing service market is driven by a growing shortage of specialized perfusionists and the high capital cost of equipment. The extracorporeal membrane oxygenation (ECMO) outsourcing service encompasses third-party specialized firms providing clinical management, equipment maintenance, and technical staffing for ECMO. This allows healthcare facilities to offer life-saving cardiac and respiratory support without the high capital investment and intensive training required to manage complex ECMO programs in-house.
The use of AI in the extracorporeal membrane oxygenation (ECMO) outsourcing service market is increasing, as it analyzes real-time ECMO data and predicts disease complications, offering early alerts. It also optimizes various ECMO parameters, enhancing its operational efficiency. At the same time, AI also helps outsourced ECMO systems in remote patient monitoring, integration with ICU platforms, and training.
The outsourcing providers are developing various tele-ECMO models and mobile ECMO support teams, which are increasing their acceptance rates for remote specialist consultations and emergency conditions.
The applications of the ECMO outsourcing services are increasing, which is driving their demand for training, data management, simulation programs, and quality assurance services to enhance patient outcomes and support the hospital personnel.
There is a rise in the use of digital health tools and remote monitoring solutions in the outsourcing services, which is enabling the real-time monitoring and optimization of clinical decisions, improving the efficiency of the ECMO systems.
| Key Elements | Scope |
| Market Size in 2026 | USD 1.62 Billion |
| Projected Market Size in 2035 | USD 3.58 Billion |
| CAGR (2026 - 2035) | 9.24% |
| Leading Region | North America by 41% |
| Market Segmentation | By Service Type, By Application, By Patient Type, By End-User, By Region |
| Top Key Players | Getinge AB (Maquet), Medtronic plc, Fresenius Medical Care (Xenios AG), LivaNova PLC, Terumo Corporation, Abbott Laboratories, Nipro Corporation, MicroPort Scientific Corporation, OriGen Biomedical, Inc. |
Why Did the Clinical Management Segment Dominate in the Market in 2025?
The clinical management segment held the largest share of approximate 58% in the extracorporeal membrane oxygenation (ECMO) outsourcing service market in 2025, due to its enhanced patient care. They also offered ECMO expertise, which increased patient adherence and outcomes.
The training & education segment is expected to show the highest growth during the upcoming years, due to growing innovations. Their complex procedures and increasing adoption rates are also increasing their demand for training and education. Additionally, increasing online platforms are also enhancing their use.
How Cardiac Support Segment Dominated the Market in 2025?
The cardiac support segment led the extracorporeal membrane oxygenation (ECMO) outsourcing service market with an approximate 52% share in 2025, due to growth in cardiac diseases. This increased the demand for ECMO outsourcing services, where the growth in surgeries also increased their use.
ECPR (Resuscitation)
The ECPR (resuscitation) segment is expected to show the fastest growth rate during the upcoming years, due to its enhanced survival rates. Additionally, the increasing development of portable ECMO systems is also increasing their use in emergency conditions, enhancing patient outcomes.
Which Patient Type Segment Held the Dominating Share of the Market in 2025?
The adult segment held the dominating share of approximate 62% in the extracorporeal membrane oxygenation (ECMO) outsourcing service market in 2025, due to growth in chronic diseases. Moreover, the rise in surgeries and transplantations also increased the demand for ECMO outsourcing services.
Pediatric
The pediatric segment is expected to show the highest growth during the predicted time, due to rising congenital heart defects. The growing health awareness and expanding paediatric care units are also increasing the use of ECMO outsourcing services. Furthermore, the growing technological innovations are also enhancing their adoption rates.
What Made Tertiary Care Hospitals the Dominant Segment in the Market in 2025?
The tertiary care hospitals segment led the extracorporeal membrane oxygenation (ECMO) outsourcing service market with an approximate 70% share in 2025, due to the growth in the patient volume. Additionally, 24/7 care and advanced infrastructure also increased their demand.
ASCs
The ASCs segment is expected to show the fastest growth rate during the predicted time, due to growing outpatient services. Moreover, the presence of affordable services and advanced technologies is also attracting patients. Additionally, their streamlined care and expanding network are also increasing their use.

North America dominated the extracorporeal membrane oxygenation (ECMO) outsourcing service market with approximate 41% in 2025, due to the presence of advanced critical care infrastructure. The growth in the early adoption of outsourcing models to mitigate hospital staffing shortages and increased healthcare investments also contributed to the market growth.
U.S. Market Trends
The U.S. consists of advanced healthcare systems, which are increasing the adoption of various ECMO systems, driving the demand for ECMO outsourcing services. The growing telemedicine platforms are also increasing their use for real-time patient monitoring, decision support, and predictive alerts, which are leading to new collaborations.
Asia Pacific is expected to host the fastest-growing extracorporeal membrane oxygenation (ECMO) outsourcing service market during the forecast period, due to expanding healthcare. The increasing prevalence of cardiovascular diseases, technological innovations, and shortage of skilled ECMO personnel are also increasing their adoption rates, enhancing the market growth.
China Market Trends
China is experiencing rapid hospital modernization, which is increasing the use of ECMO outsourcing services. Additionally, the growing disease burden and lack of trained ECMO specialists are also increasing the demand. The growing government initiatives and technological advancements are also encouraging their use.
Europe is expected to grow significantly in the extracorporeal membrane oxygenation (ECMO) outsourcing service market during the forecast period, due to growing clinical awareness. The presence of advanced healthcare infrastructure, an increasingly skilled workforce, and growing government support are also increasing the adoption of the ECMO outsourcing service, promoting market growth.
UK Market Trends
The presence of a well-developed healthcare system in the UK is increasing the use of ECMO outsourcing services to support the hospital staff and offer remote care, to tackle the increasing cardiovascular and respiratory diseases. Moreover, their demand is also increasing to overcome the shortage of skilled personnel by promoting their training programs.


| Companies | Headquarters | Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service |
| Getinge AB (Maquet) | Gothenburg, Sweden | Modular equipment solutions, clinical education, and maintenance |
| Medtronic plc | Dublin, Ireland | Clinical education and technical training |
| Fresenius Medical Care (Xenios AG) | Bad Homburg, Germany | Extensive training and on-site clinical application support for Novalung and Medos ECMO platforms |
| LivaNova PLC | London, UK | Turnkey ECMO systems |
| Terumo Corporation | Tokyo, Japan | Clinical specialists and perfusionists led training and equipment implementation. |
| Abbott Laboratories | Illinois, U.S. | CentriMag acute circulatory support system |
| Nipro Corporation | Osaka, Japan | Oxygenators and tubing sets |
| MicroPort Scientific Corporation | Shanghai, China | Technical servicing and clinical training for Vitaspring |
| Eurosets S.r.l. | Medolla, Italy | ECMOLife system |
| OriGen Biomedical, Inc. | Texas, U.S. | Manufacture specialized ECMO and cannulae accessories. |
By Service Type
By Application
By Patient Type
By End-User
By Region
February 2026
January 2026